Galcanezumab (Emgality) for Migraine and Cluster Headaches

Am Fam Physician. 2020 Apr 15;101(8):502-503.

Authors

Jennifer Ren-Si Cheung¹, Deborah R Erlich²

Affiliations

¹ Tufts University School of Medicine and Cambridge Health Alliance, Boston, MA, USA.
² Tufts University School of Medicine and Beth Israel Lahey Health, Boston, MA, USA.

PMID: 32293845

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Cluster Headache* / drug therapy
Double-Blind Method
Humans
Migraine Disorders* / drug therapy
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
galcanezumab
erenumab